Long-Term Durability and Stability of Amlitelimab Efficacy in Adults With Moderate-to-Severe Atopic Dermatitis: 52-Week Post Hoc Analysis of the STREAM-AD Phase 2b Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s607, 2025. DOI: 10.25251/qx64pd52. Disponível em: https://skin.dermsquared.com/skin/article/view/3813. Acesso em: 30 apr. 2026.